Cite
HARVARD Citation
Burge, D. et al. (2017). Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study. Lupus. pp. 825-834. [Online].